US 9814762
Targeted therapeutic proteins
granted A61KA61K2039/505A61K2039/515
Quick answer
US patent 9814762 (Targeted therapeutic proteins) held by BIOMARIN PHARMACEUTICAL INC. expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOMARIN PHARMACEUTICAL INC.
- Grant date
- Tue Nov 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K2039/505, A61K2039/515, A61K35/12, A61K35/54